These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2202223)

  • 1. Renal pathology in owl monkeys in Plasmodium falciparum vaccine trials.
    Iseki M; Broderson JR; Pirl KG; Igarashi I; Collins WE; Aikawa M
    Am J Trop Med Hyg; 1990 Aug; 43(2):130-8. PubMed ID: 2202223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization trials with the ring-infected erythrocyte surface antigen of Plasmodium falciparum in owl monkeys (Aotus vociferans).
    Collins WE; Pappaioanou M; Anders RF; Campbell GH; Brown GV; Kemp DJ; Broderson JR; Coppel RL; Skinner JC; Procell PM
    Am J Trop Med Hyg; 1988 Mar; 38(2):268-82. PubMed ID: 3281493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerulopathy in squirrel monkeys with acute Plasmodium falciparum infection.
    Aikawa M; Jacobs G; Whiteley HE; Igarashi I; Ristic M
    Am J Trop Med Hyg; 1988 Jan; 38(1):7-14. PubMed ID: 3277466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal pathology in Saimiri monkeys during a vaccine trial using the recombinant circumsporozoite protein of Plasmodium vivax.
    Tegoshi T; Broderson JR; Iseki M; Oo MM; Collins WE; Aikawa M
    Am J Trop Med Hyg; 1991 Apr; 44(4):406-12. PubMed ID: 2042706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.
    Kumar S; Yadava A; Keister DB; Tian JH; Ohl M; Perdue-Greenfield KA; Miller LH; Kaslow DC
    Mol Med; 1995 Mar; 1(3):325-32. PubMed ID: 8529111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of owl monkeys with the ring-infected erythrocyte surface antigen of Plasmodium falciparum.
    Collins WE; Anders RF; Ruebush TK; Kemp DJ; Woodrow GC; Campbell GH; Brown GV; Irving DO; Goss N; Filipski VK
    Am J Trop Med Hyg; 1991 Jan; 44(1):34-41. PubMed ID: 1996739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal pathology in owl monkeys vaccinated with Plasmodium falciparum asexual blood-stage synthetic peptide antigens.
    Nagatake T; Broderson JR; Tegoshi T; Collins WE; Aikawa M
    Am J Trop Med Hyg; 1992 Nov; 47(5):614-20. PubMed ID: 1449202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum.
    Enders B; Hundt E; Knapp B
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():413-22. PubMed ID: 1343721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and efficacy trials in Aotus nancymai monkeys with model compounds representing parts of a 75-kD merozoite surface antigen of Plasmodium falciparum.
    Sharma P; Ruebush TK; Campbell GH; Richman SJ; Wilkins PP; Broderson JR; Ardeshir F; Gross M; Silverman C; Skinner JC
    Am J Trop Med Hyg; 1992 Jun; 46(6):691-707. PubMed ID: 1621894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and function of candidate vaccine antigens in Plasmodium falciparum.
    Anders RF; Murray LJ; Thomas LM; Davern KM; Brown GV; Kemp DJ
    Biochem Soc Symp; 1987; 53():103-14. PubMed ID: 3332761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of Aotus monkeys with recombinant cysteine-rich interdomain region 1 alpha protects against severe disease during Plasmodium falciparum reinfection.
    Makobongo MO; Keegan B; Long CA; Miller LH
    J Infect Dis; 2006 Mar; 193(5):731-40. PubMed ID: 16453270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficiency of human Plasmodium falciparum malaria vaccine candidates in Aotus lemurinus monkeys.
    Herrera S; Herrera MA; Certa U; Corredor A; Guerrero R
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():423-8. PubMed ID: 1343722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum.
    Collins WE; Anders RF; Pappaioanou M; Campbell GH; Brown GV; Kemp DJ; Coppel RL; Skinner JC; Andrysiak PM; Favaloro JM
    Nature; 1986 Sep 18-24; 323(6085):259-62. PubMed ID: 2429187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen.
    Jones TR; Narum DL; Gozalo AS; Aguiar J; Fuhrmann SR; Liang H; Haynes JD; Moch JK; Lucas C; Luu T; Magill AJ; Hoffman SL; Sim BK
    J Infect Dis; 2001 Jan; 183(2):303-312. PubMed ID: 11110648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies in owl monkeys leading to the development of a synthetic vaccine against the asexual blood stages of Plasmodium falciparum.
    Rodriguez R; Moreno A; Guzman F; Calvo M; Patarroyo ME
    Am J Trop Med Hyg; 1990 Oct; 43(4):339-54. PubMed ID: 2240362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parasitized erythrocyte membrane antigens of Plasmodium brasilianum: relationships with the ring-infected erythrocyte surface antigen of Plasmodium falciparum.
    Sulzer AJ; Collins WE; Cantella RA; Carney WP
    Am J Trop Med Hyg; 1995 Dec; 53(6):618-23. PubMed ID: 8561264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccination against malaria: current status and perspectives].
    Dubois P; Pereira da Silva L
    Rev Prat; 1988 Jun; 38(18):1173-7. PubMed ID: 3051302
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara.
    Thera MA; Coulibaly D; Kone AK; Guindo AB; Traore K; Sall AH; Diarra I; Daou M; Traore IM; Tolo Y; Sissoko M; Niangaly A; Arama C; Baby M; Kouriba B; Sissoko MS; Sagara I; Toure OB; Dolo A; Diallo DA; Remarque E; Chilengi R; Noor R; Sesay S; Thomas A; Kocken CH; Faber BW; Imoukhuede EB; Leroy O; Doumbo OK
    Malar J; 2016 Aug; 15(1):442. PubMed ID: 27577237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards a malaria vaccine: what is in sight?
    del Giudice G
    Allergol Immunopathol (Madr); 1991; 19(3):129-35. PubMed ID: 1799171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.